statistiche ricercatore

RUBINO, TIZIANA

Distribuzione geografica

Continente	#
NA - Nord America	9.319
EU - Europa	5.673
AS - Asia	1.153
SA - Sud America	16
Continente sconosciuto - Info sul continente non disponibili	11
AF - Africa	8
OC - Oceania	3
Totale	16.183

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	9.276
IT - Italia	3.124
UA - Ucraina	920
SE - Svezia	555
TR - Turchia	437
VN - Vietnam	280
CN - Cina	252
DE - Germania	243
IE - Irlanda	240
FI - Finlandia	237
GB - Regno Unito	164
SG - Singapore	129
FR - Francia	71
CA - Canada	39
BE - Belgio	27
JP - Giappone	27
CZ - Repubblica Ceca	26
NL - Olanda	17
EU - Europa	11
RU - Federazione Russa	8
BR - Brasile	6
CH - Svizzera	6
BG - Bulgaria	5
CL - Cile	5
IN - India	5
DK - Danimarca	4
HU - Ungheria	4
ES - Italia	3
HK - Hong Kong	3
KR - Corea	3
MD - Moldavia	3
MX - Messico	3
MY - Malesia	3
NG - Nigeria	3
NO - Norvegia	3
AE - Emirati Arabi Uniti	2
AR - Argentina	2
AU - Australia	2
CO - Colombia	2
MA - Marocco	2
PH - Filippine	2
PL - Polonia	2
PT - Portogallo	2
SM - San Marino	2
ZA - Sudafrica	2
AL - Albania	1
EG - Egitto	1
GR - Grecia	1
ID - Indonesia	1
IL - Israele	1
IR - Iran	1
JO - Giordania	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LI - Liechtenstein	1
LU - Lussemburgo	1
MM - Myanmar	1
MN - Mongolia	1
MT - Malta	1
NZ - Nuova Zelanda	1
PA - Panama	1
PK - Pakistan	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
TW - Taiwan	1
VE - Venezuela	1
Totale	16.183

Salva come PNG Salva come JPEG

Città	#
Milan	2.004
Fairfield	1.355
Woodbridge	851
Chandler	755
Ashburn	714
Jacksonville	709
Houston	665
Seattle	583
Ann Arbor	534
Wilmington	510
Cambridge	467
Dearborn	272
Princeton	257
Nyköping	248
Dublin	239
Izmir	222
Como	176
Boardman	165
Rome	155
Dong Ket	142
Singapore	115
New York	107
San Mateo	93
San Diego	71
Chicago	58
Ogden	44
Beijing	43
Washington	38
London	34
Norwalk	30
Santa Clara	30
Toronto	30
Los Angeles	27
Munich	27
Hefei	26
Tokyo	26
Brussels	25
Brno	24
Helsinki	23
Ponte Lambro	22
Kunming	21
Nanjing	21
Verona	18
Mcallen	17
Kocaeli	15
Carbonara Al Ticino	14
Nanchang	14
Berlin	13
Redwood City	12
Varese	12
Guangzhou	11
Jinan	11
Düsseldorf	9
Dallas	8
Ottawa	8
Redmond	8
Auburn Hills	7
Cagliari	7
Cairate	7
Edinburgh	7
Falls Church	7
Frankfurt am Main	7
Fuzhou	7
Gallarate	7
Gavirate	7
Palermo	7
Amsterdam	6
Istanbul	6
Phoenix	6
Salerno	6
Bologna	5
Kilburn	5
Lappeenranta	5
Marnate	5
Oristano	5
Prescot	5
Shanghai	5
Shenyang	5
Sofia	5
Wandsworth	5
Ankara	4
Benevento	4
Bollate	4
Borgomanero	4
Chengdu	4
Chiswick	4
Chongqing	4
Hounslow	4
Naples	4
Perugia	4
San Giuliano Milanese	4
Segrate	4
Southwark	4
Stockholm	4
Stuttgart	4
Turin	4
Zhengzhou	4
Atlanta	3
Bari	3
Budapest	3
Totale	12.349

Salva come PNG Salva come JPEG

Nome	#
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex	246
Cannabinoidi ed ansia: meccanismi cellulari/molecolari e ruolo degli endocannabinoidi nella modulazione degli stati ansiosi	244
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	225
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats	217
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2	205
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	199
Assay of GTPγS binding in autoradiography	197
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	196
Correlati cellulari e molecolari dell'abuso di Salvia divinorum: ruolo dei recettori cannabici e k oppioidi	196
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour	194
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	193
Long lasting consequences of cannabis exposure in adolescence.	190
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence.	190
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice	190
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol.	189
Adolescent exposure to cannabis as a risk factor for psychiatric disorders	189
New vistas on cannabis use disorder	186
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine	184
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.	184
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	183
A molecular basis of analgesic tolerance to cannabinoids	181
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism	176
Cannabinoids and opioids share cAMP pathway in rat splenocytes	172
Endocannabinoids and Mental Disorders.	169
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function	162
Role of endocannabinoids in regulating drug dependence	161
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors.	159
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine	157
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring	157
Cannabinoids and Drugs of abuse	156
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.	155
Modulation of rat brain cannabinoid receptors after chronic morphine treatment	154
The endocannabinoid system and schizophrenia: integration of evidence.	154
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT?	154
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling	154
Chronic Delta(9)-THC Exposure Differently Affects Histone Modifications in the Adolescent and Adult Rat Brain	152
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats.	151
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.	151
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	150
Sex-dependent vulnerability to cannabis abuse in adolescence	148
Molecular and cellular basis of cannabinoid and opioid interactions	147
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex	147
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood	144
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.	144
Cellular mechanisms underlying the interaction between cannabinoid and opioid system	142
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.	141
Endocannabinoids and Drug Dependence	140
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.	139
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats	139
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems	137
Endocannabinoids in the immune system and cancer	136
The psychoactive ingredient of marijuana induces behavioural sensitization	135
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain	135
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models	135
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments	134
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940	133
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects	133
The endocannabinoid system and psychiatric disorders.	133
null	132
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain	130
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade	127
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.	127
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.	124
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats	123
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages	122
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure	122
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models	122
Neurobiological mechanisms underlying cannabis-induced memory impairment	122
Presence of a reduced opioid response in interleukin-6 knock out mice	121
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas.	120
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line	117
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system	117
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models	114
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine.	113
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.	113
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	112
Modulation of extracellular signal-regulated kinases cascade by cronic Delta(99-tetrahydrocannabinol treatment	112
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition.	110
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization	109
Is cannabinoid transmission involved in rewarding properties of drugs of abuse	109
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.	109
Pertussis toxin modifies the effect of central morphine on rat intestinal motility.	105
Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood	105
Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently.	103
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze	102
Termination of acute stress response by the endocannabinoid system is regulated through LSD1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL	98
Cholera toxin antagonizes morphine-induced catalepsy through a cyclic AMP-independent mechanism.	96
Studio sperimentale dell'interazione tra abuso di steroidi anabolizzanti e cannabinoidi nella depressione: dall'analisi comportamentale ai substrati cellulari	94
ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta 9-tetrahydrocannabinol exposure	93
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.	93
Ruolo emergente dei meccanismi epigenetici e della neuroinfiammazione nei disturbi associate al consume di cannabis	93
Presence of a reduced opioid response in interleukin-6 knock out mice.	92
The role of the endogenous cannabinoid system in drug addiction.	91
Bombesin receptor antagonist. 2. Analogues based on substance P antagonists	91
CB1 cannabinoid and mu opioid receptors density and functionality are altered in rats self-administering either heroin or the CB1 receptor agonist WIN 55,212-2	90
Il sistema endocannabinoide	90
PLOS One	90
Effect of chronic exposure to naltrexone and opioid selective agonists on G protein mRNA levels in the rat nervous system.	88
Behavioral, proteomic and lipidomic analyses in adult male and female rats exposed to cannabinoids during adolescence: an integrative approach to identify markers of vulnerability for psychiatric disorders and drug abuse	86
Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization.	85
Totale	14.176

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	58.867
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	58.867

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	2.271	0	0	0	0	249	391	459	401	286	229	66	190
2020/2021	2.349	67	229	102	202	156	263	122	167	341	139	229	332
2021/2022	1.413	144	162	114	183	52	61	61	73	59	209	121	174
2022/2023	1.951	188	132	123	257	97	417	2	272	249	72	107	35
2023/2024	3.372	505	534	514	580	623	302	17	69	70	53	36	69
2024/2025	592	43	47	356	91	55	0	0	0	0	0	0	0
Totale													16.326